Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$280,727
-$22,263 QoQ
Shares Held
2,222
+2.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,694
of 2,266 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DAVIS R M INC holds $148,422,330 across 9 Drug Manufacturers - General names. GILD ranks #9 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
61,458 | $73,714,575 | |
| 2 | JNJ |
Johnson & Johnson
|
249,911 | $63,469,896 | |
| 3 | ABBV |
AbbVie Inc.
|
18,009 | $4,531,784 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,586 | $3,030,801 | |
| 5 | AMGN |
Amgen Inc
|
6,701 | $2,426,566 | |
| 6 | AZN |
Astrazeneca PLC
|
1,871 | $354,779 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,425 | $312,588 | |
| 8 | PFE |
Pfizer Inc
|
12,484 | $300,614 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $280,727 | 2,222 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $302,990 | 2,174 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $211,603 | 1,724 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $210,234 | 1,894 | Shares | Sole | 2025-11-12 | |
| 2020-12-31 | $216,785 | 3,721 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $210,422 | 3,330 | Shares | Sole | 2020-12-01 | |
| 2020-06-30 | $279,292 | 3,630 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $226,672 | 3,032 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||